[Cl:1][C:2]1[C:9]([N+:10]([O-:12])=[O:11])=[CH:8][C:5]([CH2:6][NH2:7])=[CH:4][C:3]=1[F:13].[F:14][C:15]([F:23])([F:22])[C:16]1([C:19](O)=[O:20])[CH2:18][CH2:17]1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C=O)C>[Cl:1][C:2]1[C:9]([N+:10]([O-:12])=[O:11])=[CH:8][C:5]([CH2:6][NH:7][C:19]([C:16]2([C:15]([F:23])([F:22])[F:14])[CH2:18][CH2:17]2)=[O:20])=[CH:4][C:3]=1[F:13]The sub-title compound was prepared in analogy to the procedure in Example 94, step (c) using 4-chloro-3-fluoro-5-nitro-benzylamine (761 mg; 3.72 mmol), 1-trifluoromethyl-cyclopropanecarboxylic acid (573 mg; 3.72 mmol), HBTU (1.41 g; 3.72 mmol), TEA (753 mg; 7.44 mmol) and DMF (10 mL).
読み込み中…